John Scholler

13.8k citations

68 papers · 7.0k indexed · 7 hit papers · h-index 29

Oncology top 0.2%
- CAR-T cell therapy research 49
Immunology top 0.5%
- Immune Cell Function and Interaction 13
- T-cell and B-cell Immunology 9
Genetics top 1%
- Virus-based gene therapy research 14
Biomedical Engineering top 1%
Molecular Biology top 5%
- Viral Infectious Diseases and Gene Expression in Insects 10
- CRISPR and Genetic Engineering 9
Epidemiology
- Trypanosoma species research and implications 8
Public Health, Environmental and Occupational Health
- Research on Leishmaniasis Studies 7

Co-authors: Carl H. June Brian Keith Sònia Guedan Avery D. Posey Steven Μ. Albelda Shannon E. McGettigan Michael C. Milone Yangbing Zhao
Cited by: Oncology Immunology Genetics
Journals: Blood (13 papers)Molecular and Biochemical Parasitology (7 papers)Proceedings of the National Academy of Sciences (4 papers)
Partner nations: United States Finland Slovakia

In The Last Decade

John Scholler

63 papers receiving 6.9k citations

Hit Papers

7 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2023 Nature Communications
2018 JCI Insight
2017 Cell Reports
2016 Immunity
2015 Cancer Research
2013 Cancer Immunology Research
2012 Science Translational Medicine

Peers

Countries citing papers authored by John Scholler

Since Specialization

Citations

This map shows the geographic impact of John Scholler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Scholler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Scholler more than expected).

Fields of papers citing papers by John Scholler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Scholler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Scholler. The network helps show where John Scholler may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John Scholler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Scholler Line = papers co-authored together John Scholler links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CAR Binders Affect CAR T-cell Tonic Signaling, Durability, and Sensitivity to Target Cancer Immunology Research ·Deepa Shukla,Khatuna Gabunia,Shannon E. McGettigan,Volodymyr Prykhodko,Shannon Christensen,Ting–Jia Fan,Decheng Song,Yanping Luo,Yanling Wang,Huaishan Wang,Regina M. Young,Carl H. June,John Scholler,James L. Riley	2025	1
2	IL7 increases targeted lipid nanoparticle–mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation Proceedings of the National Academy of Sciences ·Caitlin M. Tilsed,Dean R. Berry,Tyler E. Papp,AIR COMMAND AND STAFF COLL MAXWELL AFB AL,Kenji Kimura,Estela Noguera-Ortega,John Scholler,Sugee Lee MacKay,Haig Aghajanian,Adrian Bot,Barbara L. Mui,Ying K. Tam,Drew Weissman,Carl H. June,Steven Μ. Albelda,Hamideh Parhiz	2024	24
3	ZFP36 disruption is insufficient to enhance the function of mesothelin-targeting human CAR-T cells Scientific Reports ·David Mai,J. Dequeker,ジョエルシャピロ,Sipriyadi,John Scholler,Neil C. Sheppard,Carl H. June	2024	1
4	Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation Nature Communications ·Sandy Montañola,Yuqi Xie,Oscar A. Aguilar,Oz Pomp,Omar Johnson,Amanda Finck,Nils W. Engel,Linhui Chen,Nicolas Plachta,John Scholler,Lewis L. Lanier,Carl H. June,Neil C. Sheppard	2024	19
5	Identifying highly active anti-CCR4 CAR T cells for the treatment of T-cell lymphoma Blood Advances ·Rupali Panwar,Renhua H. Li,Shunichiro Kuramitsu,Philip S. Wang,Tong Da,Sangya Agarwal,Decheng Song,John Scholler,Antonia Rotolo,Avery D. Posey,Alain H. Rook,Paul Haun,Marco Ruella,Regina M. Young,Carl H. June	2023	27
6	Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74 Clinical Cancer Research ·王缉胜,Estela Noguera-Ortega,Zebin Xiao,Leslie Todd,John Scholler,Decheng Song,Maria Liousia,LU Xun-wen,Kexiang Xu,Kimberly J. Edwards,Michael D. Farwell,Carl H. June,Steven Μ. Albelda,Ellen Puré,Mark A. Sellmyer	2022	34
7	Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting Nature Communications ·Adham S. Bear,Tatiana Blanchard,V. V. Guretskii,Michael Ford,Lee P. Richman,Chong Xu,Miren L. Baroja,Sarah McCuaig,Geoff Mallory,Khatuna Gabunia,John Scholler,Avery D. Posey,Mark H. O’Hara,Anže Smole,Daniel J. Powell,Benjamin A. García,Robert H. Vonderheide,Gerald P. Linette,Beatriz M. Carreno	2021	73
8	Bispecific Antibody Armed Metabolically Enhanced Headless CAR T Cells Frontiers in Immunology ·Archana Thakur,John Scholler,L. H. de Oliveira,Marina Yurievna Maksimova,Dana L. Schalk,Carl H. June,Lawrence G. Lum	2021	13
9	A rational mouse model to detect on-target, off-tumor CAR T cell toxicity JCI Insight ·Mauro Castellarin,Caroline Sands,Tong Da,John Scholler,Kathleen Graham,Elizabeth L. Buza,Joseph A. Fraietta,Yangbing Zhao,Carl H. June	2020	72
10	Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study Journal of Cancer Research and Clinical Oncology ·Archana Thakur,John Scholler,Dana L. Schalk,Carl H. June,Lawrence G. Lum	2020	14
11	Reducing Ex Vivo Culture Improves the Antileukemic Activity of Chimeric Antigen Receptor (CAR) T Cells Cancer Immunology Research ·Saba Ghassemi,Selene Nuñez-Cruz,Roddy S. O’Connor,Joseph A. Fraietta,Prachi Patel,John Scholler,David M. Barrett,Stefan Lundh,Megan M. Davis,Felipe Bedoya,Changfeng Zhang,John Leferovich,Simon F. Lacey,Bruce L. Levine,Stephan A. Grupp,Carl H. June,J. Joseph Melenhorst,Michael C. Milone	2018	212
12	Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses JCI Insight ·Keisuke Watanabe,Yanping Luo,Tong Da,Sònia Guedan,Marco Ruella,John Scholler,Brian Keith,Regina M. Young,Boris Engels,Suvi Sorsa,Mikko Siurala,Riikka Havunen,Siri Tähtinen,Akseli Hemminki,Carl H. June	2018	215
13	Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells Cancer Immunology Research ·Matthew J. Frigault,Ji‐Hyun Lee,Maria C. Basil,Carmine Carpenito,Shinichiro Motohashi,John Scholler,Omkar U. Kawalekar,Sònia Guedan,Shannon E. McGettigan,Avery D. Posey,Sonny Ang,Laurence J.N. Cooper,Jesse M. Platt,F. Brad Johnson,Chrystal M. Paulos,Yangbing Zhao,Michael Kalos,Michael C. Milone,Carl H. June	2015	233
14	Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors Clinical Cancer Research ·Edmund K. Moon,Liang-Chuan Wang,Douglas V. Dolfi,Caleph B. Wilson,Raghuveer Ranganathan,Jing Sun,Veena Kapoor,John Scholler,Ellen Puré,Michael C. Milone,Carl H. June,James L. Riley,E. John Wherry,Steven Μ. Albelda	2014	344
15	Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells Blood ·Saar Gill,Sarah K. Tasian,Marco Ruella,Olga Shestova,Yong Li,David L. Porter,Martin Carroll,Gwenn Danet-Desnoyers,John Scholler,Stephan A. Grupp,Carl H. June,Michael Kalos	2014	363
16	Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicitybreakdown → Cancer Immunology Research ·Liang‐Chuan S. Wang,Albert Lo,John Scholler,Jing Sun,R. Sonali Majumdar,Veena Kapoor,Michael Antzis,Cody E. Cotner,Laura A. Johnson,Amy C. Durham,Charalambos Solomides,Carl H. June,Ellen Puré,Steven Μ. Albelda	2013	515
17	Multiple Injections of Electroporated Autologous T Cells Expressing a Chimeric Antigen Receptor Mediate Regression of Human Disseminated Tumor Cancer Research ·Yangbing Zhao,Edmund K. Moon,Carmine Carpenito,Chrystal M. Paulos,Xiaojun Liu,Andrea Brennan,Anne Chew,Richard G. Carroll,John Scholler,Bruce L. Levine,Steven Μ. Albelda,Carl H. June	2010	366
18	Externalization of the Leaderless Cytokine IL-1F6 Occurs in Response to Lipopolysaccharide/ATP Activation of Transduced Bone Marrow Macrophages The Journal of Immunology ·Unja Martin,John Scholler,Jesse L. Gurgel,Blair R. Renshaw,John E. Sims,Christopher A. Gabel	2009	40
19	LeIF: A Recombinant Leishmania Protein That Induces an IL-12-Mediated Th1 Cytokine Profile The Journal of Immunology ·Yasir A. W. Skeiky,Mary K. Kennedy,David Kaufman,Monamaris Marques Borges,Jeffrey A. Guderian,John Scholler,Pamela J. Ovendale,Kathleen S. Picha,Philip Morrissey,Kenneth H. Grabstein,Antonio Campos‐Neto,Steven G. Reed	1998	131
20	The Human p167 Gene Encodes a Unique Structural Protein That Contains Centrosomin A Homology and Associates with a Multicomponent Complex DNA and Cell Biology ·John Scholler,Steven B. Kanner	1997	16

About John Scholler

John Scholler is a scholar working on Oncology, Immunology, Genetics, Immunology and Allergy and Molecular Biology, having authored 68 papers that have together received 7.0k indexed citations. Recurring topics across this work include CAR-T cell therapy research (49 papers), Virus-based gene therapy research (14 papers), Immune Cell Function and Interaction (13 papers), Viral Infectious Diseases and Gene Expression in Insects (10 papers), CRISPR and Genetic Engineering (9 papers), T-cell and B-cell Immunology (9 papers), Trypanosoma species research and implications (8 papers) and Research on Leishmaniasis Studies (7 papers). The work is most often cited by research in Oncology (5.5k citations), Immunology (2.6k citations), Genetics (1.7k citations), Biomedical Engineering (1.7k citations) and Molecular Biology (2.3k citations). John Scholler has collaborated with scholars based in United States, Finland and Slovakia. Frequent co-authors include Carl H. June, Brian Keith, Sònia Guedan, Avery D. Posey, Steven Μ. Albelda, Shannon E. McGettigan, Michael C. Milone, Yangbing Zhao, Omkar U. Kawalekar and Prachi Patel. Their work appears in journals such as Blood, Molecular and Biochemical Parasitology, Proceedings of the National Academy of Sciences, Cancer Immunology Research and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact